The expression of FADS1, which is also important for the viability and self-renewal of GBM cancer stem cells [20], does not differ between GBM tumors and healthy brain tissue, according to GEPIA [9], Seifert et al. [8], and previous results from our research team [21]. The gene discussed is FADS1; the disease is glioblastoma.